Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 3.700
+0.100 (2.70%)
Aug 14, 2025, 5:24 PM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 22.43 million as of August 14, 2025. Its market cap has decreased by -51.91% in one year.
Market Cap
22.43M
Enterprise Value
2.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.70
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 22.43M, an increase of 25.46%. That is a compound annual growth rate of 1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 22.43M | -44.40% |
| Dec 31, 2024 | 40.34M | -48.30% |
| Dec 31, 2023 | 78.02M | -17.30% |
| Dec 29, 2022 | 94.35M | -55.64% |
| Dec 30, 2021 | 212.71M | -1.36% |
| Dec 31, 2020 | 215.65M | 332.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 64.35B |
| Danel (Adir Yeoshua) | 2.50B |
| Kamada | 1.43B |
| Bait Bakfar | 1.06B |
| SofWave Medical | 977.04M |
| BrainsWay | 788.52M |
| Novolog (Pharm-Up 1966) | 709.61M |
| Ilex Medical | 673.41M |